Vascular Endothelial Growth Factor Inhibitor [EPC]: Side Effects & Safety Data for 5 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Vascular Endothelial Growth Factor Inhibitor [EPC] includes 5 drugs with a combined 120,426 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
5
Drugs in Class
120,426
Combined Reports
All Vascular Endothelial Growth Factor Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| BEVACIZUMAB | JOBEVNE | 78,112 | 17,498 | 23,114 | 22.4% |
| AFLIBERCEPT | EYLEA | 26,891 | 8,527 | 3,193 | 31.7% |
| RANIBIZUMAB | CIMERLI | 15,284 | 2,651 | 2,265 | 17.3% |
| BEVACIZUMAB-MALY | ALYMSYS | 121 | 20 | 28 | 16.5% |
| BEVACIZUMAB-TNJN | Avzivi tnjn | 18 | 0 | 11 | N/A |
Common Side Effects in Vascular Endothelial Growth Factor Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Death | 18,420 | 18,404 |
| Off label use | 14,717 | 3,775 |
| Diarrhoea | 5,307 | 1,162 |
| Disease progression | 5,200 | 1,879 |
| Fatigue | 4,879 | 1,384 |
| Hypertension | 4,823 | 571 |
| Nausea | 4,716 | 1,061 |
| Drug ineffective | 4,280 | 521 |
| Visual impairment | 3,899 | 54 |
| Vomiting | 3,388 | 820 |